Latanoprost/timolol
< Latanoprost
| Combination of | |
|---|---|
| Latanoprost | Prostaglandin |
| Timolol | Beta blocker |
| Clinical data | |
| Trade names | Xalacom |
| Routes of administration | Eye drops |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
Latanoprost/timolol, sold under the brand name Xalacom, is a combination drug used for the treatment of glaucoma, consisting of latanoprost (increase uveoscleral outflow of aqueous humor) and timolol (a beta blocker decreasing the production of aqueous fluid).